SCHEMBL21243223

SCHEMBL21243223

OC[C@H]1O[C@@H](O[C@H]2[C@@H](O)[C@@H](CO)O[C@@H](O[C@H]3[C@H](O)[C@@H](O)C(O)O[C@@H]3CO)[C@@H]2O)[C@H](O)[C@@H](O)[C@H]1O

nearest known ligand 0.62

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LGALS8 O00214 1/20 0.57
▸ LGALS3 P17931 1/20 0.57
▸ LGALS4 P56470 1/20 0.57
▸ MEN1 O00255 2/20 0.51
▸ KMT2A Q03164 2/20 0.51
▸ AMY2A P04746 2/20 0.51
▸ ENGASE Q8NFI3 1/20 0.50
▸ CD209 Q9NNX6 1/20 0.50
▸ FGF1 P05230 1/20 0.47
▸ FGF2 P09038 1/20 0.47
▸ VEGFA P15692 1/20 0.47
▸ HPSE Q9Y251 1/20 0.47
▸ TYR P14679 2/20 0.47
▸ AMY1A P0DUB6 1/20 0.47
▸ TSHR P16473 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ GJA1 P17302 1/20 0.46
▸ GJB2 P29033 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31614391 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31701579 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700326 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700334 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31614389 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL295024 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL3149886 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31614393 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL295220 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A
SCHEMBL31700630 1.00 LGALS8 (0.57) LGALS8LGALS3LGALS4MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250361477-A1 PRODUCTION OF AN OLIGOSACCHARIDE MIXTURE BY A CELL INBIOSE NV (BE) 2025-11-27 — — US disclosed
EP-3509438-B1 NUTRITIONAL COMPOSITIONS FOR INFANTS AND/OR YOUNG CHILDREN COMPRISING OLIGOSACCHARIDES NESTLE SA (CH) 2025-01-22 — — EP disclosed
CN-116472346-A Production of sialylated oligosaccharide mixtures by cells 因比奥斯公司 2023-07-21 — — CN disclosed
CN-116323958-A Production of oligosaccharide mixtures by cells 因比奥斯公司 2023-06-23 — — CN disclosed
CN-116234919-A Production of mixtures of neutral fucosylated oligosaccharides by cells 因比奥斯公司 2023-06-06 — — CN disclosed
CN-116096912-A Production of a mixture of neutral nonfucosylated oligosaccharides by cells 因比奥斯公司 2023-05-09 — — CN disclosed
US-11384110-B2 Method for removing residual organic solvent from a crystalline oligosaccharide GLYCOM A/S (DK) 2022-07-12 — — US disclosed
US-20190248824-A1 METHOD FOR REMOVING RESIDUAL ORGANIC SOLVENT FROM A CRYSTALLINE OLIGOSACCHARIDE GLYCOM A/S (DK) 2019-08-15 — — US disclosed
Send feedback